Ausgabe 1/2010
Inhalt (25 Artikel)
Is 123I-MIBG cardiac scintigraphy a surrogate marker for Parkinson’s disease?
Hidenao Fukuyama
Validation of cardiac 123I-MIBG scintigraphy in patients with Parkinson’s disease who were diagnosed with dopamine PET
Kenji Ishibashi, Yuko Saito, Shigeo Murayama, Kazutomi Kanemaru, Keiichi Oda, Kiichi Ishiwata, Hidehiro Mizusawa, Kenji Ishii
Predictive potential of pre-operative functional neuroimaging in patients treated with subthalamic stimulation
Stelvio Sestini, Alberto Pupi, Franco Ammannati, Silvia Ramat, Sandro Sorbi, Roberto Sciagrà, Luigi Mansi, Antonio Castagnoli
The impact of reconstruction method on the quantification of DaTSCAN images
John C. Dickson, Livia Tossici-Bolt, Terez Sera, Kjell Erlandsson, Andrea Varrone, Klaus Tatsch, Brian F. Hutton
Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study
Silvia Morbelli, Arnoldo Piccardo, Giampiero Villavecchia, Barbara Dessi, Andrea Brugnolo, Alessandra Piccini, Anna Caroli, Giovanni Frisoni, Guido Rodriguez, Flavio Nobili
68Ga-somatostatin analogues PET and 18F-DOPA PET in medullary thyroid carcinoma
Valentina Ambrosini, Maria Cristina Marzola, Domenico Rubello, Stefano Fanti
Comparison of 68Ga-DOTATATE and 18F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma
Brendon G. Conry, Nikolaos D. Papathanasiou, Vineet Prakash, Irfan Kayani, Martyn Caplin, Shahid Mahmood, Jamshed B. Bomanji
PET imaging of medullary thyroid carcinoma in MEN2A transgenic mice using 6-[18F]F-L-DOPA
Carine Pestourie, Benoît Thézé, Bertrand Kuhnast, Stéphane Le Helleix, Karine Gombert, Frédéric Dollé, Bertrand Tavitian, Frédéric Ducongé
Detection of unknown primary neuroendocrine tumours (CUP-NET) using 68Ga-DOTA-NOC receptor PET/CT
Vikas Prasad, Valentina Ambrosini, Merten Hommann, Dieter Hoersch, Stefano Fanti, Richard P. Baum
Sentinel lymph node biopsy in pregnant patients with breast cancer
Oreste Gentilini, Marta Cremonesi, Antonio Toesca, Nicola Colombo, Fedro Peccatori, Roberto Sironi, Claudia Sangalli, Nicole Rotmensz, Guido Pedroli, Giuseppe Viale, Paolo Veronesi, Viviana Galimberti, Aron Goldhirsch, Umberto Veronesi, Giovanni Paganelli
Volumetry of [11C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme
Norbert Galldiks, Roland Ullrich, Michael Schroeter, Gereon R. Fink, Lutz W. Kracht
Assessment of long-term radiotoxicity after treatment with the low-dose-rate alpha-particle-emitting radioimmunoconjugate 227Th-rituximab
Jostein Dahle, Thora J. Jonasdottir, Helen Heyerdahl, Jahn M. Nesland, Jørgen Borrebæk, Anne Kristine Hjelmerud, Roy H. Larsen
Predictive implications of bone turnover markers after palliative treatment with 186Re-HEDP in hormone-refractory prostate cancer patients with painful osseous metastases
Athanasios Zafeirakis, Georgios Papatheodorou, Athanasios Arhontakis, Athanasios Gouliamos, Lambros Vlahos, Georgios S. Limouris
Nuclisome: a novel concept for radionuclide therapy using targeting liposomes
Amelie Fondell, Katarina Edwards, Ludger M. Ickenstein, Stefan Sjöberg, Jörgen Carlsson, Lars Gedda
Somatostatin receptor scintigraphy might be useful for detecting skeleton abnormalities in patients with multiple myeloma and plasmacytoma
Ali Agool, Riemer H. J. A. Slart, Rudi A. J. O. Dierckx, Philip M. Kluin, Lydia Visser, Pieter L. Jager, Edo Vellenga
PROLARA: prognosis-based lifetime attributable risk approximation for cancer from diagnostic radiation exposure
Wolfgang Eschner, Matthias Schmidt, Markus Dietlein, Harald Schicha
Diagnostic value of [18F]-FDG PET/CT in children with fever of unknown origin or unexplained signs of inflammation
Niklas Jasper, Jan Däbritz, Michael Frosch, Markus Loeffler, Matthias Weckesser, Dirk Foell
New starch-based radiotracer for lung perfusion scintigraphy
Franck Lacoeuille, François Hindré, Benoit Denizot, Francis Bouchet, Pierre Legras, Olivier Couturier, Serge Askiénazy, Jean Pierre Benoit, Jean Jacques Le Jeune
Unifying the predictive value of pretransplant FDG PET in patients with lymphoma: a review and meta-analysis of published trials
Loukia S. Poulou, Loukas Thanos, Panayiotis D. Ziakas
Multimodality imaging in Europe: a survey by the European Association of Nuclear Medicine (EANM) and the European Society of Radiology (ESR)
Alberto Cuocolo, Éamann Breatnach
Radiation burden in myocardial imaging: an old concern in the new age of hi-tech, hybrid imaging
Giovanni Lucignani
PET aerosol lung scintigraphy using Galligas
Jörg Kotzerke, Michael Andreeff, Gerd Wunderlich
C. B. Benson and E. I. Bluth, Ultrasonography in obstetrics and gynecology. A practical approach, 2nd edition
Massimo Vallone, Gianfranco Vallone
Increased uptake of 131I-MIBG after intra-arterial application in liver metastases of a neuroendocrine tumor
Manuel Popp, Annette Strumpf, Klaus Zöphel, Christian Stroszczynski, Jörg Kotzerke
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
Ronald Boellaard, Mike J. O’Doherty, Wolfgang A. Weber, Felix M. Mottaghy, Markus N. Lonsdale, Sigrid G. Stroobants, Wim J. G. Oyen, Joerg Kotzerke, Otto S. Hoekstra, Jan Pruim, Paul K. Marsden, Klaus Tatsch, Corneline J. Hoekstra, Eric P. Visser, Bertjan Arends, Fred J. Verzijlbergen, Josee M. Zijlstra, Emile F. I. Comans, Adriaan A. Lammertsma, Anne M. Paans, Antoon T. Willemsen, Thomas Beyer, Andreas Bockisch, Cornelia Schaefer-Prokop, Dominique Delbeke, Richard P. Baum, Arturo Chiti, Bernd J. Krause